These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21782944)

  • 1. Antibody-mediated allograft rejection: the emerging role of endothelial cell signalling and transcription factors.
    Naemi FM; Ali S; Kirby JA
    Transpl Immunol; 2011 Sep; 25(2-3):96-103. PubMed ID: 21782944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation.
    Dragun D
    Transplantation; 2008 Oct; 86(8):1019-25. PubMed ID: 18946337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway.
    Narayanan K; Jendrisak MD; Phelan DL; Mohanakumar T
    Transpl Immunol; 2006 Jan; 15(3):187-97. PubMed ID: 16431285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-mediated rejection: treatment alternatives and outcomes.
    Singh N; Pirsch J; Samaniego M
    Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-mediated organ-allograft rejection.
    Colvin RB; Smith RN
    Nat Rev Immunol; 2005 Oct; 5(10):807-17. PubMed ID: 16175181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological function of the endothelial cell within the setting of organ transplantation.
    Taflin C; Charron D; Glotz D; Mooney N
    Immunol Lett; 2011 Sep; 139(1-2):1-6. PubMed ID: 21641935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-donor HLA class I antibodies: pathways to endothelial cell activation and cell-mediated allograft rejection.
    Naemi FM; Carter V; Kirby JA; Ali S
    Transplantation; 2013 Aug; 96(3):258-66. PubMed ID: 23823649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-mediated rejection in lung transplantation: myth or reality?
    Glanville AR
    J Heart Lung Transplant; 2010 Apr; 29(4):395-400. PubMed ID: 20338509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation.
    Carter V; Shenton BK; Jaques B; Turner D; Talbot D; Gupta A; Chapman CE; Matthews CJ; Cavanagh G
    Transplant Proc; 2005 Mar; 37(2):654-7. PubMed ID: 15848491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and hyperacute humoral rejection in kidney allograft recipients treated with anti-human thymocyte antibodies.
    Colovai AI; Vasilescu ER; Foca-Rodi A; Kim-Schulze S; Hussaini N; D'agati VD; Markowitz GS; Wang C; Cohen DJ; Hardy MA; Suciu-Foca N
    Hum Immunol; 2005 May; 66(5):501-12. PubMed ID: 15935887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-human leukocyte antigen antibodies reactive with endothelial cells could be involved in early loss of renal allografts.
    Ronda C; Borba SC; Ferreira SC; Glotz D; Ianhez LE; Rodrigues H; Viggiani CS; Nahas W; David-Neto E; Castro MC; David Daisa SR; Kalil J; Panajotopoulos N
    Transplant Proc; 2011 May; 43(4):1345-8. PubMed ID: 21620126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial cells as targets of allograft rejection.
    Glotz D; Lucchiari N; Pegaz-Fiornet B; Suberbielle-Boissel C
    Transplantation; 2006 Jul; 82(1 Suppl):S19-21. PubMed ID: 16829788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration.
    Jindra PT; Zhang X; Mulder A; Claas F; Veale J; Jin YP; Reed EF
    Transplantation; 2006 Jul; 82(1 Suppl):S33-5. PubMed ID: 16829793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of MICA and other non-HLA antibodies in clinical transplantation.
    Sumitran-Holgersson S
    Curr Opin Immunol; 2008 Oct; 20(5):607-13. PubMed ID: 18675346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against mesangial cells and their secretory products in chronic renal allograft rejection in the rat.
    Paul LC; Muralidharan J; Muzaffar SA; Manting EH; Valentin JF; de Heer E; Kashgarian M
    Am J Pathol; 1998 May; 152(5):1209-23. PubMed ID: 9588890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.
    Dragun D; Müller DN; Bräsen JH; Fritsche L; Nieminen-Kelhä M; Dechend R; Kintscher U; Rudolph B; Hoebeke J; Eckert D; Mazak I; Plehm R; Schönemann C; Unger T; Budde K; Neumayer HH; Luft FC; Wallukat G
    N Engl J Med; 2005 Feb; 352(6):558-69. PubMed ID: 15703421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection.
    Sis B; Halloran PF
    Curr Opin Organ Transplant; 2010 Feb; 15(1):42-8. PubMed ID: 20009933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of immunologic response in chronic allograft rejection].
    Boratyńska M
    Postepy Hig Med Dosw; 2003; 57(4):405-24. PubMed ID: 14601251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preformed cytotoxic antibodies in potential allograft recipients: recent data.
    Cecka JM; Zhang Q; Reed EF
    Hum Immunol; 2005 Apr; 66(4):343-9. PubMed ID: 15866696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.